View Author
patient trial treatment ef ficacy study phase infusion brand kiovig gammagard score ficacy preparation difference ivig brands flammatory demyelinating polyradiculoneuropathy disability sum score research group schmitz pi immunoglobulin disease value neurology randomised product baseline outcome range muscle neurol flammatory demyelinating scale outcome measures signi ficant differences netherland double-blind european federation analysis measure open-label phase safety society baxter disability month center flammatory demyelinating polyneuropathy december baxter healthcare bv rotterdam handicap scale signi psychiatry neuropathy erasmus mc grant muscle strength double-blind phase immune-mediated polyneuropathies neurosurg ivig preparations kawasaki disease assessor ivig preparation ivig dosage nerve research council university schmitz ficant guillain-barre syndrome fatigue strength dosage number downloaded measurement vigorimeter group.bmj.com
3 Most Recent Publications
|
Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: An open-label single-center study
(Article)
Vries, J.M. de Beek, N.A.M.E. van der Faber, C.G. Verschuuren, J.J. Kruijshaar, M.E. Reuser, A.J.J. Doorn, P.A. van Ploeg, A.T. van der Hop, W.C.J. Karstens, F.P. Wokke, J.H.J. Visser, M. de Engelen, B.G. van Kuks, J.B.M. Kooi, A.J. van der Notermans, N.C. |
2012-09-28
|
|
Randomised controlled trial comparing two different intravenous immunoglobulins in chronic inflammatory demyelinating polyradiculoneuropathy
(Article)
Kuitwaard, K. Berg, L.H. van den Hop, W.C.J. Doorn, P.A. van Vermeulen, M. Brusse, E. Cats, E.A. Kooi, A.J. van der Notermans, N.C. Pol, W.L. van der Schaik, I.N. van Nes, S.I. van |
2010-12-01
|
|
The Dutch neuromuscular database CRAMP (Computer Registry of All Myopathies and Polyneuropathies): Development and preliminary data
(Article)
Engelen, B.G. van Veenendaal, H. van Doorn, P.A. van Faber, C.G. Hoeven, J.H. van der Janssen, N.G. Notermans, N.C. Schaik, I.N. van Visser, L.H. Verschuuren, J.J. |
2007-01-01
|
